Skip to main content

How and where is the Sublocade injection given?

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 21, 2023.

Official answer

by Drugs.com

Sublocade should only be administered into the stomach area (abdomen), except for a 2-inch circle around your navel (belly button), as a subcutaneous (under the skin) injection. It must be given by a certified healthcare provider who has met certain qualifying requirements, including only prescribing Sublocade for the treatment of opioid dependence. Sublocade is administered monthly with a minimum of 26 days between doses.

Sublocade must not be administered intravenously, intramuscularly, or intradermally and each injection should be administered only using the syringe and safety needle included with the product

References

Sublocade (buprenorphine). Updated 02/2020. Indivior Inc. https://www.drugs.com/pro/sublocade.html

Read next

It is available in a number of dosage forms under the brand names Sublocade, Brixadi, Probuphine (discontinued), Belbuca, Butrans, Buprenex, and Subutex (discontinued). Continue reading

Sublocade and Brixadi are both subcutaneous long-acting buprenorphine injections that may be used for the maintenance treatment of opioid misuse disorder in adults. Sublocade was approved on November 30, 2017, and Brixadi was approved on May 23, 2023. Sublocade is administered once a month, with a minimum of 26 days between doses. If extended travel is deemed necessary, a single 300mg injection may be given to cover 2 months. Brixadi is given once a week or once a month. Continue reading

Most patients with Medicaid typically pay low or no cost for Sublocade (buprenorphine) if it is a preferred drug treatment by their state health plan. Your health plan and costs are determined by your state Medicaid program. Continue reading

Related medical questions

Drug information

Related support groups

Medical Disclaimer